| Dr Elena Balestreire Hawryluk, MD, PHD | |
|
300 Longwood Ave, Fegan 6th Floor, Dermatology, Boston, MA 02115-5724 | |
| (617) 355-6117 | |
| Not Available |
| Full Name | Dr Elena Balestreire Hawryluk |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 15 Years |
| Location | 300 Longwood Ave, Boston, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275761496 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 254723 (Massachusetts) | Secondary |
| 207NP0225X | Dermatology - Pediatric Dermatology | 254723 (Massachusetts) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Massachusetts General Physicians Organization Inc | 2466365820 | 3085 |
| Children's Hospital Pediatric Associates, Inc | 3476541830 | 246 |
News Archive
Communities across the United States are developing programs to address child bullying. New research shows that parents can play an important role in preventing their children from becoming bullies in the first place.
Immune system cells of the brain, which scavenge pathogens and damaged neurons, are also key players in memory and learning, according to new research by Duke neuroscientists.
Australian researchers have developed a novel technique that tracks proteins "behaving badly" and may have found a way that leads to new treatments for brain disease. The team believes the discovery could help in the development of drugs to treat diseases such as Alzheimer's, Parkinson's and Huntington's.
"Republicans are accusing Democrats of using 'scare tactics' to convince Americans the GOP wants an end to Medicare and Social Security. In the party's weekly radio address, Sen. Dean Heller of Nevada says both parties should come together to fix those programs ... 'Let's stop the lies about who wants to end Medicare or eliminate Social Security and fix both programs now,' Heller says".
GlaxoSmithKline plc and Innoviva, Inc. announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion today supporting the use of Trelegy Ellipta in a broader group of patients with moderate to severe chronic obstructive pulmonary disease and that labeling, if approved, will be updated to further reflect its effect on exacerbations of COPD.
› Verified 9 days ago
| Entity Name | Massachusetts General Physicians Organization Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801874573 PECOS PAC ID: 2466365820 Enrollment ID: O20031111000434 |
News Archive
Communities across the United States are developing programs to address child bullying. New research shows that parents can play an important role in preventing their children from becoming bullies in the first place.
Immune system cells of the brain, which scavenge pathogens and damaged neurons, are also key players in memory and learning, according to new research by Duke neuroscientists.
Australian researchers have developed a novel technique that tracks proteins "behaving badly" and may have found a way that leads to new treatments for brain disease. The team believes the discovery could help in the development of drugs to treat diseases such as Alzheimer's, Parkinson's and Huntington's.
"Republicans are accusing Democrats of using 'scare tactics' to convince Americans the GOP wants an end to Medicare and Social Security. In the party's weekly radio address, Sen. Dean Heller of Nevada says both parties should come together to fix those programs ... 'Let's stop the lies about who wants to end Medicare or eliminate Social Security and fix both programs now,' Heller says".
GlaxoSmithKline plc and Innoviva, Inc. announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion today supporting the use of Trelegy Ellipta in a broader group of patients with moderate to severe chronic obstructive pulmonary disease and that labeling, if approved, will be updated to further reflect its effect on exacerbations of COPD.
› Verified 9 days ago
| Entity Name | Dana-farber Cancer Institute, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851333686 PECOS PAC ID: 9133038904 Enrollment ID: O20040223000228 |
News Archive
Communities across the United States are developing programs to address child bullying. New research shows that parents can play an important role in preventing their children from becoming bullies in the first place.
Immune system cells of the brain, which scavenge pathogens and damaged neurons, are also key players in memory and learning, according to new research by Duke neuroscientists.
Australian researchers have developed a novel technique that tracks proteins "behaving badly" and may have found a way that leads to new treatments for brain disease. The team believes the discovery could help in the development of drugs to treat diseases such as Alzheimer's, Parkinson's and Huntington's.
"Republicans are accusing Democrats of using 'scare tactics' to convince Americans the GOP wants an end to Medicare and Social Security. In the party's weekly radio address, Sen. Dean Heller of Nevada says both parties should come together to fix those programs ... 'Let's stop the lies about who wants to end Medicare or eliminate Social Security and fix both programs now,' Heller says".
GlaxoSmithKline plc and Innoviva, Inc. announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion today supporting the use of Trelegy Ellipta in a broader group of patients with moderate to severe chronic obstructive pulmonary disease and that labeling, if approved, will be updated to further reflect its effect on exacerbations of COPD.
› Verified 9 days ago
| Entity Name | Children's Hospital Pediatric Associates, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457306664 PECOS PAC ID: 3476541830 Enrollment ID: O20040504000964 |
News Archive
Communities across the United States are developing programs to address child bullying. New research shows that parents can play an important role in preventing their children from becoming bullies in the first place.
Immune system cells of the brain, which scavenge pathogens and damaged neurons, are also key players in memory and learning, according to new research by Duke neuroscientists.
Australian researchers have developed a novel technique that tracks proteins "behaving badly" and may have found a way that leads to new treatments for brain disease. The team believes the discovery could help in the development of drugs to treat diseases such as Alzheimer's, Parkinson's and Huntington's.
"Republicans are accusing Democrats of using 'scare tactics' to convince Americans the GOP wants an end to Medicare and Social Security. In the party's weekly radio address, Sen. Dean Heller of Nevada says both parties should come together to fix those programs ... 'Let's stop the lies about who wants to end Medicare or eliminate Social Security and fix both programs now,' Heller says".
GlaxoSmithKline plc and Innoviva, Inc. announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion today supporting the use of Trelegy Ellipta in a broader group of patients with moderate to severe chronic obstructive pulmonary disease and that labeling, if approved, will be updated to further reflect its effect on exacerbations of COPD.
› Verified 9 days ago
| Entity Name | The General Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023049236 PECOS PAC ID: 6507803806 Enrollment ID: O20080313000351 |
News Archive
Communities across the United States are developing programs to address child bullying. New research shows that parents can play an important role in preventing their children from becoming bullies in the first place.
Immune system cells of the brain, which scavenge pathogens and damaged neurons, are also key players in memory and learning, according to new research by Duke neuroscientists.
Australian researchers have developed a novel technique that tracks proteins "behaving badly" and may have found a way that leads to new treatments for brain disease. The team believes the discovery could help in the development of drugs to treat diseases such as Alzheimer's, Parkinson's and Huntington's.
"Republicans are accusing Democrats of using 'scare tactics' to convince Americans the GOP wants an end to Medicare and Social Security. In the party's weekly radio address, Sen. Dean Heller of Nevada says both parties should come together to fix those programs ... 'Let's stop the lies about who wants to end Medicare or eliminate Social Security and fix both programs now,' Heller says".
GlaxoSmithKline plc and Innoviva, Inc. announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion today supporting the use of Trelegy Ellipta in a broader group of patients with moderate to severe chronic obstructive pulmonary disease and that labeling, if approved, will be updated to further reflect its effect on exacerbations of COPD.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Elena Balestreire Hawryluk, MD, PHD 300 Longwood Ave, Fegan 6th Floor, Dermatology, Boston, MA 02115-5724 Ph: (617) 355-6117 | Dr Elena Balestreire Hawryluk, MD, PHD 300 Longwood Ave, Fegan 6th Floor, Dermatology, Boston, MA 02115-5724 Ph: (617) 355-6117 |
News Archive
Communities across the United States are developing programs to address child bullying. New research shows that parents can play an important role in preventing their children from becoming bullies in the first place.
Immune system cells of the brain, which scavenge pathogens and damaged neurons, are also key players in memory and learning, according to new research by Duke neuroscientists.
Australian researchers have developed a novel technique that tracks proteins "behaving badly" and may have found a way that leads to new treatments for brain disease. The team believes the discovery could help in the development of drugs to treat diseases such as Alzheimer's, Parkinson's and Huntington's.
"Republicans are accusing Democrats of using 'scare tactics' to convince Americans the GOP wants an end to Medicare and Social Security. In the party's weekly radio address, Sen. Dean Heller of Nevada says both parties should come together to fix those programs ... 'Let's stop the lies about who wants to end Medicare or eliminate Social Security and fix both programs now,' Heller says".
GlaxoSmithKline plc and Innoviva, Inc. announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion today supporting the use of Trelegy Ellipta in a broader group of patients with moderate to severe chronic obstructive pulmonary disease and that labeling, if approved, will be updated to further reflect its effect on exacerbations of COPD.
› Verified 9 days ago
Erica Dommasch, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 330 Brookline Ave, Shapiro 2, Boston, MA 02215 Phone: 617-667-3753 | |
Dr. Chantal Louise Cotter, MB BCH BAO Dermatology Medicare: Not Enrolled in Medicare Practice Location: 300 Longwood Ave, Boston, MA 02115 Phone: 617-355-6117 | |
Dr. John J Croke, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 725 Albany St, Shapiro 8, Boston, MA 02118 Phone: 617-638-7420 Fax: 617-638-7289 | |
Dr. Debjani Sahni, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 725 Albany Street, Shapiro 8, Boston, MA 02118 Phone: 617-638-7420 Fax: 617-638-7289 | |
Dr. Joseph C Kvedar, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 50 Staniford St, Suite 200, Boston, MA 02114 Phone: 617-726-2914 Fax: 617-724-2135 | |
Ryan Char Kelm, Dermatology Medicare: Medicare Enrolled Practice Location: 50 Staniford St # 250, Boston, MA 02114 Phone: 617-724-6960 | |
Dr. David Attar Hashemi, MD, MBA Dermatology Medicare: Medicare Enrolled Practice Location: 50 Staniford St, Boston, MA 02114 Phone: 617-726-2914 |